Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
作者： Wendy Lim , Francesco Dentali , John W. Eikelboom , Mark A. Crowther
DOI: 10.7326/0003-4819-144-9-200605020-00011
关键词:
摘要: The authors analyzed studies of bleeding rates in patients who were taking low-molecular-weight heparin. Patients have a creatinine clearance 30 mL/min or less and are enoxaparin have...
core.ac.uk
sci-hub.se 参考文章(56)
P. Mismetti, S. Laporte-Simitsidis, C. Navarro, P. Sié, P. d’Azemar, J. Necciari, J. P. Duret, C. Gaud, H. Decousus, B. Boneu, Aging and Venous Thromboembolism Influence the Pharmacodynamics of the Anti-Factor Xa and Anti-thrombin Activities of a Low Molecular Weight Heparin (Nadroparin) Thrombosis and Haemostasis. ,vol. 79, pp. 1162- 1165 ,(1998) , 10.1055/S-0037-1615034
Philippe Cestac, Haleh Bagheri, Maryse Lapeyre-Mestre, Pierre Si??, Atoussa Fouladi, Eric Maupas, Philippe L??ger, Bernard Fontan, Patrice Massip, Jean-Louis Montastruc, Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients. Drug Safety. ,vol. 26, pp. 197- 207 ,(2003) , 10.2165/00002018-200326030-00005
M Laposata, R C Sosolik, E M Van Cott, D Green, S H Goodnight, T W Barrowcliffe, College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Archives of Pathology & Laboratory Medicine. ,vol. 122, pp. 799- 807 ,(1998)
Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580
René Bruno, Pascale Baille, Sylvie Retout, Nicole Vivier, Christine Veyrat-Follet, Ger-Jan Sanderink, Richard Becker, Elliott M. Antman, Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction. British Journal of Clinical Pharmacology. ,vol. 56, pp. 407- 414 ,(2003) , 10.1046/J.1365-2125.2003.01904.X
Sarah A Spinler, Stephanie M Inverso, Marc Cohen, Shaun G Goodman, Kathleen A Stringer, Elliott M Antman, ESSENCE and TIMI 11B Investigators, Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. American Heart Journal. ,vol. 146, pp. 33- 41 ,(2003) , 10.1016/S0002-8703(03)00121-2
S. L. Kane-Gill, Y. Feng, M. B. Bobek, R. R. Bies, M. C. Pruchnicki, J. F. Dasta, Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety. Journal of Clinical Pharmacy and Therapeutics. ,vol. 30, pp. 207- 213 ,(2005) , 10.1111/J.1365-2710.2005.00634.X
Isabelle Mahé, Ludovic Drouet, Olivier Chassany, Anne-Sophie Grenard, Charles Caulin, Jean-François Bergmann, Low molecular weight heparin for the prevention of deep venous thrombosis: a suitable monitoring in elderly patients? Pathophysiology of Haemostasis and Thrombosis. ,vol. 32, pp. 134- 136 ,(2002) , 10.1159/000065216
J HULOT, G MONTALESCOT, P LECHAT, J COLLET, A ANKRI, S URIEN, Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome. Clinical Pharmacology & Therapeutics. ,vol. 77, pp. 542- 552 ,(2005) , 10.1016/J.CLPT.2005.02.012
Donna F Stroup, Jesse A Berlin, Sally C Morton, Ingram Olkin, G David Williamson, Drummond Rennie, David Moher, Betsy J Becker, Theresa Ann Sipe, Stephen B Thacker, Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting JAMA. ,vol. 283, pp. 2008- 2012 ,(2000) , 10.1001/JAMA.283.15.2008